Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2010-03-10

FDA Approved: COUNTERACT ALLERGY — Supplemental Application (Melaleuca, Inc.)

View source ↗

Summary

The FDA approved Melaleuca, Inc.'s supplemental application for COUNTERACT ALLERGY (loratadine), resulting in a labeling update for the product. Loratadine is i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COUNTERACT ALLERGY (Loratadine)

Snippet

SUPPL AP for COUNTERACT ALLERGY (LORATADINE)